Literature DB >> 13916969

Equilibrium dialysis studies of the binding of thyroxine by human serum albumin.

K STERLING, P ROSEN, M TABACHNICK.   

Abstract

Entities:  

Keywords:  SERUM ALBUMIN/metabolism; THYROXIN/blood

Mesh:

Substances:

Year:  1962        PMID: 13916969      PMCID: PMC291007          DOI: 10.1172/JCI104552

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  11 in total

1.  Measurement of free thyroxine concentration in human serum.

Authors:  K STERLING; A HEGEDUS
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

2.  Azoproteins. II. A spectrophotometric study of the coupling of diazotized arsanilic acid with proteins.

Authors:  M TABACHNICK; H SOBOTKA
Journal:  J Biol Chem       Date:  1960-04       Impact factor: 5.157

3.  Regulation of the peripheral metabolism of the thyroid hormones.

Authors:  S H INGBAR; N FREINKEL
Journal:  Recent Prog Horm Res       Date:  1960

4.  The binding of L-tryptophan in human plasma at 37 degrees C.

Authors:  R H MCMENAMY; C C LUND; J VAN MARCKE; J L ONCLEY
Journal:  Arch Biochem Biophys       Date:  1961-04       Impact factor: 4.013

5.  Metabolism of L-thyroxine by human tissue slices.

Authors:  E C ALBRIGHT; F C LARSON
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

6.  The specific binding of L-tryptophan to serum albumin.

Authors:  R H McMENAMY; J L ONCLEY
Journal:  J Biol Chem       Date:  1958-12       Impact factor: 5.157

7.  Proteins associated with the thyroid hormones.

Authors:  J ROBBINS; J E RALL
Journal:  Physiol Rev       Date:  1960-07       Impact factor: 37.312

8.  The interaction of thyroid hormones and protein in biological fluids.

Authors:  J ROBBINS; J E RALL
Journal:  Recent Prog Horm Res       Date:  1957

9.  Preparation of human serum albumin free of long-chain fatty acids.

Authors:  D S GOODMAN
Journal:  Science       Date:  1957-06-28       Impact factor: 47.728

10.  The kinetics of the inhibition by thyroxine of the cupric chloride catalyzed oxidation of ascorbic acid.

Authors:  C L GEMMILL; R L PLUNKETT
Journal:  Arch Biochem Biophys       Date:  1952-04       Impact factor: 4.013

View more
  8 in total

1.  MOLECULAR STRUCTURE OF THYROXINE IN RELATION TO ITS BINDING BY HUMAN SERUM ALBUMIN.

Authors:  K STERLING
Journal:  J Clin Invest       Date:  1964-09       Impact factor: 14.808

2.  MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS.

Authors:  T F YUE; P G DAYTON; A B GUTMAN
Journal:  J Clin Invest       Date:  1963-08       Impact factor: 14.808

3.  Measurement of free thyroxine concentration in human serum.

Authors:  K STERLING; A HEGEDUS
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

4.  Thyroid hormone binding by a component of mitochondrial membrane.

Authors:  K Sterling; P O Milch
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

5.  Relative binding affinities of integrin antagonists by equilibrium dialysis and liquid chromatography-mass spectrometry.

Authors:  William J Tipping; Nkazimulo Tshuma; James Adams; Harvey T Haywood; James E Rowedder; M Jonathan Fray; Thomas McInally; Simon J F Macdonald; Neil J Oldham
Journal:  ACS Med Chem Lett       Date:  2014-12-22       Impact factor: 4.345

6.  [Determination of triiothyronine binding to serum proteins by means of dextran gel filtration].

Authors:  P C Scriba; R Landgraf; H G Heinze; K Schwarz
Journal:  Klin Wochenschr       Date:  1966-01-15

7.  Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation.

Authors:  K Sterling; M A Brenner
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

8.  Studies on the coumarin anticoagulant drugs: interaction of human plasma albumin and warfarin sodium.

Authors:  R A O'Reilly
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.